The Second Manifestations of Arterial Disease 2 (SMART2) model, intended for individuals with a previous CVD event, also considers chronic kidney disease (CKD) and high-sensitivity C-reactive protein (CRP) levels to predict future events in addition to the standard factors [28]. The gene discussed is CRP; the disease is arterial disorder.